
|Videos|February 12, 2016
- Gastrointestinal Cancers: mCRC (Issue 6)
- Volume 1
- Issue 6
Dr. Jennifer Wu on Proliferations and Mutations in Colorectal Cancer
Author(s)Jennifer Wu, MD
Jennifer Wu, MD, discusses the issue of deficiencies in enzymes that fix mismatch repairs in colorectal cancer. Wu says targeting the cancer-specific enzymes which allow tumors to repair themselves could stop tumor growth in patients.
Jennifer Wu, MD, assistant professor of medicine, NYU School of Medicine, discusses the issue of deficiencies in enzymes that fix mismatch repairs in colorectal cancer. Wu says targeting the cancer-specific enzymes which allow tumors to repair themselves could stop tumor growth in patients.
Articles in this issue
almost 10 years ago
Early Development of Regorafenib: Was the Correct Dose Selected?almost 10 years ago
Clinical Review: Regorafenib in Refractory mCRCalmost 10 years ago
Optimizing Outcomes With Regorafenib in Metastatic CRCalmost 10 years ago
Patient Populations Provide Sequencing Clues in Chemorefractory CRCalmost 10 years ago
Dr. Cathy Eng on Bevacizumab Plus FOLFOXIRI for Patients With mCRC




































